| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue |
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit |
-
|
-
|
-
| | | Operating Expenses | | Research Development | 4,644 | 6,328 | 2,666 | | Selling General and Administrative | 2,676 | 3,811 | 1,439 | | Non Recurring |
-
|
-
| 13 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (7,319) | (10,138) | (4,117) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 128 | 299 | 18 | | Earnings Before Interest And Taxes | (7,191) | (9,840) | (4,099) | | Interest Expense | 14 | 53 |
-
| | Income Before Tax | (7,205) | (9,892) | (4,099) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (7,205) | (9,892) | (4,099) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (7,205) | (9,892) | (4,099) | | Preferred Stock And Other Adjustments |
-
| (12,410) | (761) | | | Net Income Applicable To Common Shares | ($7,205) | ($22,302) | ($4,860) |
|
0.29% Nasdaq 
0.0166 (2.91%) 
Income Statement
